References
- Le Guehennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater. 2007;23:844-54.
- Puleo DA, Nanci A. Understanding and controlling the bone implant interface. Biomaterials. 1999;20:2311-21.
- Chu TM, Warden SJ, Turner CH, Stewart RL. Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2. Biomaterials. 2007;28:459-67.
- Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun. 1991;174:96-101.
- Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects: a randomized controlled trial. J Bone Joint Surg Am. 2006;88:1431-41.
- Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone. 2002;30:816-22.
- Wikesjo UM, Qahash M, Thomson RC, Cook AD, Rohrer MD, Wozney JM, et al. rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res. 2004;15:194-204.
- Hall J, Sorensen RG, Wozney JM, Wikesjo UM. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J Clin Periodontol. 2007;34:444-51.
- Yoo D, Tovar N, Jimbo R, Marin C, Anchieta RB, Machado LS, et al. Increased osseointegration effect of bone morphogenetic protein 2 on dental implants: an in vivo study. J Biomed Mater Res A. 2014;102:1921-7.
- Zheng Y, Wu G, Liu T, Liu Y, Wismeijer D, Liu Y. A novel BMP2-coprecipitated, layer-by-layer assembled biomimetic calcium phosphate particle: a biodegradable and highly efficient osteoinducer. Clin Implant Dent Relat Res. 2014;16:643-54.
- Lan J, Wang ZF, Shi B, Xia HB, Cheng XR. The influence of recombinant human BMP-2 on bone-implant osseointegration: biomechanical testing and histomorphometric analysis. Int J Oral Maxillofac Surg. 2007;36:345-9.
- Jeon O, Song SJ, Kang SW, Putnam AJ, Kim BS. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials. 2007;28:2763-71.
- Schliephake H, Aref A, Scharnweber D, Bierbaum S, Roessler S, Sewing A. Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation. Clin Oral Implants Res. 2005;16:563-9.
- Choi JW, Heo SJ, Koak JY, Kim SK, Lim YJ, Kim SH, et al. Biological responses of anodized titianium implants under different current voltages. J Oral Rehabil. 2006;33:889-97.
- Choi KH, Moon K, Kim SH, Yun JH, Jang KL, Cho KS. Purification and biological activity of recombinant human bone morphogenetic protein-2 produced by E. coli expression system. J Korean Acad Periodontol. 2008;38:41-50.
- Li LH, Kim HW, Lee SH, Kong YM, Kim HE. Biocompatibility of titanium implants modified by microarc oxidation and hydroxyapatite coating. J Biomed Mater Res A. 2005;73:48-54.
- Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M. Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factor. J Biomed Mater Res. 2001;58:449-55.
- Lee SY, Koak JY, Heo SJ, Kim SK, Lee SJ, Nam SY. Osseointegration of anodized titanium implants coated with poly(lactide-co-glycolide)/basic fibroblast growth factor by electrospray. Int J Oral Maxillofac Implants. 2010;25:315-20.
- Zong X, Kim K, Fang D, Ran S, Hsiao BS, Chu B. Structure and process relationship of electrospun bioabsorbable nanofiber membranes. Polymer (Guildf). 2002;43:4403-12.
- Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55:329-47.
- Sanchez-Duffhues G, Hiepen C, Knaus P, Ten Dijke P. Bone morphogenetic protein signaling in bone homeostasis. Bone. 2015;80:43-59.
- Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, et al. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res. 1995;10:1651-9.
- Iwasaki S, Tsuruoka N, Hattori A, Sato M, Tsujimoto M, Kohno M. Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. J Biol Chem. 1995;270:5476-82.
- Woo BH, Fink BF, Page R, Schrier JA, Jo YW, Jiang G, et al. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res. 2001;18:1747-53.
- Komori T. Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem. 2002;87:1-8.
- Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics. 2007;8:70.
- zur Nieden NI, Kempka G, Ahr HJ. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation. 2003;71:18-27.
Cited by
- (CONSORT) Wound closure using Dermabond after excision of hemangioma on the lip vol.98, pp.17, 2018, https://doi.org/10.1097/md.0000000000015342
- Bone Morphogenetic Protein 2-Conjugated Silica Particles Enhanced Early Osteogenic Differentiation of Adipose Stem Cells on the Polycaprolactone Scaffold vol.16, pp.4, 2018, https://doi.org/10.1007/s13770-019-00195-x
- The antagonistic effect of magnesium hydroxide particles on vascular endothelial activation induced by acidic PLGA degradation products vol.9, pp.3, 2018, https://doi.org/10.1039/d0bm01656j